On 3 May, TOPRA hosted a debate on the forthcoming EU referendum, to consider the issues from a pharmaceutical and regulatory affairs perspective.
As a professional association, TOPRA cannot take a position one way or another, but wanted to create an opportunity to debate an issue that is important to individual members and to the profession as a whole. Almost 40 TOPRA members attended the event, and there was a lively and wide-ranging discussion. Download the report, below.
When reading the report, be aware that it is a summary of a longer discussion. Please do not rely on anything in the report when making your decision on which way to vote.